# Safety and Tolerability of Metronidazole Gel 1.3%

> **NCT02392026** · PHASE4 · COMPLETED · sponsor: **Insud Pharma** · enrollment: 60 (actual)

## Conditions studied

- Vaginosis, Bacterial

## Interventions

- **DRUG:** Metronidazole Gel

## Key facts

- **NCT ID:** NCT02392026
- **Lead sponsor:** Insud Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-12
- **Primary completion:** 2016-10-05
- **Final completion:** 2016-10-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02392026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02392026, "Safety and Tolerability of Metronidazole Gel 1.3%". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02392026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*